| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 47.4373 | 39 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.7032 | 26 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.7172 | 26 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.6613 | 53 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.7857 | 31 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.1228 | 14 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.9796 | 41 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.7002 | 16 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.3447 | 29 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.0721 | 13 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.4926 | 39 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.1648 | 28 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.7344 | 51 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 45.0585 | 27 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.0691 | 41 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.781 | 44 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.8688 | 26 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.8779 | 48 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49 | 45 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.547 | 30 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.7607 | 26 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 42.198 | 14 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.6528 | 50 |